GSK3B and acute myeloid leukemia: In conditional mouse knockout studies, deletion of GSK-3β expression was postulated to be necessary for the establishment of myelodysplastic disease syndrome (MDS) while both GSK-3β and GSK-3α were shown to be necessary for progression to acute myeloid leukemia (AML) [21].